Showing results (1481-1490 of 6,957) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|March 6, 2018
Disease-Drug Interactions in Inflammatory States via Effects on CYP-Mediated Drug ClearanceDavid E Coutant, Stephen D HallJournal of Clinical Pharmacology|March 10, 2018
In Vivo Formation of Ethinylestradiol After Intramuscular Administration of Norethisterone EnantateChristian Friedrich, Matthias Berse, Stefan Klein, et al.Journal of Clinical Pharmacology|August 1, 1979
Effects of the beta-adrenoceptor blocking agent sotalol on CNS: sleep, EEG, and psychophysiological parametersW Bender, W Greil, E Rüther, et al.Journal of Clinical Pharmacology|August 15, 2015
Exploratory effects of a strong CYP3A inhibitor (ketoconazole), a strong CYP3A inducer (rifampicin), and concomitant ethanol on piragliatin pharmacokinetics and pharmacodynamics in type 2 diabetic patientsJianguo Zhi, Suoping Zhai, Angela Georgy, et al.Journal of Clinical Pharmacology|May 8, 2018
Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to ReportingAr Kar Aung, Mei Jie Tang, Nikki Rae Adler, et al.Journal of Clinical Pharmacology|May 8, 2018
A Randomized, Single-Center, Double-Blind, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male SubjectsKumi Matsuno, Shingo Tanaka, Takamasa Hashimoto, et al.Journal of Clinical Pharmacology|May 26, 2017
Population Pharmacokinetics and Exposure Response Assessment of CC-292, a Potent BTK Inhibitor, in Patients With Chronic Lymphocytic LeukemiaYan Li, Francisco Ramírez-Valle, Yongjun Xue, et al.Journal of Clinical Pharmacology|May 11, 2018
Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile HemangiomaTomoki Takechi, Tadao Kumokawa, Rumiko Kato, et al.Journal of Clinical Pharmacology|May 11, 2018
A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement TherapySoo Min Jang, Katherine N Gharibian, Susan J Lewis, et al.Journal of Clinical Pharmacology|May 11, 2018
A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB InhibitorJustin Dennie, Alexander G Vandell, Satoshi Inoue, et al.Pageof 696